Decision pending on diabetes medications
Should new medicines to treat type 2 diabetes be funded?
Should more than 50,000 people receive funding for the drugs?
Government drug-funding agency Pharmac is expected to decide next week whether it will fund two new medicines to treat type 2 diabetes.
Botany resident Graham King and thousands of other people who suffer from the condition hope the decision will fall in their favour.
King (pictured) pays $100 a month for Dapagliflozin, which is used to treat the condition.
Despite the cost, he said it helps control his diabetes and has cut the amount of insulin he has to take.
He said he doesn't think people should endure what he has had to to get modern medicines, like Dapagliflozin, Empagliflozin and Dulaglutide, to treat the condition.
"I'm just lucky I can afford $100 a month."
Figures released by the Ministry of Health last year showed there were 45,266 people registered in the Counties Manukau area with type 2 diabetes in 2019.
Pharmac chief executive Sarah Fitt said that next week its board will look at funding both Empagliflozin and Dulaglutide for 50,000 New Zealanders with type two diabetes who have a high risk of complications such as heart and kidney disease.
"Clinical experts told us that there is evidence for significant benefit from these two medicines in people with established or at high risk of cardiovascular and/or renal disease," she said.
Scam Alert: Fake information regarding December Bonuses from MSD
The Ministry of Social Development is reporting that fake information is circulating about new ‘December bonuses’ or ‘benefit increases’
If you get suspicious communication, please contact Netsafe.
Neighbourhood Challenge: Who Can Crack This One? ⛓️💥❔
What has a head but no brain?
Do you think you know the answer? Simply 'Like' this post if you know the answer and the big reveal will be posted in the comments at 2pm on the day!
Want to stop seeing these in your newsfeed?
Head here and hover on the Following button on the top right of the page (and it will show Unfollow) and then click it. If it is giving you the option to Follow, then you've successfully unfollowed the Riddles page.
Poll: Are Kiwis allergic to “exuberance”? 🥝
In The Post’s opinion piece on the developments set to open across Aotearoa in 2026, John Coop suggests that, as a nation, we’re “allergic to exuberance.”
We want to know: Are we really allergic to showing our excitement?
Is it time to lean into a more optimistic view of the place we call home? As big projects take shape and new opportunities emerge, perhaps it’s worth asking whether a little more confidence (and enthusiasm!) could do us some good.
-
42.5% Yes
-
33% Maybe?
-
24.5% No
Loading…
